Race to find better treatment for dangerous fungal infections in premature babies
NCT ID NCT02145832
Summary
This study compared two antifungal medications (fluconazole and micafungin) for treating suspected or confirmed fungal infections in newborns, particularly premature infants. Researchers tested whether micafungin works as well as the current standard treatment while also studying how these drugs behave in babies' developing bodies. The trial involved 100 newborns and aimed to find safer, more effective dosing strategies for these vulnerable patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANDIDIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Antwerp, Rocourt, Liège, Louvain, Namur, Belgium
-
Study site
Paris, Lyon, Saint-Pierre de La Réunion, France
-
Study site
Roma, Torino, Catania, Foggia, Reggio Emilia, Italy
-
Study site
Rotterdam, Amsterdam, Utrecht, Isala, Netherlands
-
Study site
Malaga, Salamanca, Spain
Conditions
Explore the condition pages connected to this study.